tiprankstipranks
Sage Therapeutics reported another clinical setback, says H.C. Wainwright
PremiumThe FlySage Therapeutics reported another clinical setback, says H.C. Wainwright
30d ago
Sage Therapeutics reports results from Phase 2 DIMENSION Study
Premium
The Fly
Sage Therapeutics reports results from Phase 2 DIMENSION Study
30d ago
Acumen appoints Schacterle as Chief Regulatory Officer, Head of Quality
Premium
The Fly
Acumen appoints Schacterle as Chief Regulatory Officer, Head of Quality
1M ago
Sage Therapeutics price target lowered to $14 from $17 at Scotiabank
PremiumThe FlySage Therapeutics price target lowered to $14 from $17 at Scotiabank
2M ago
Sage Therapeutics price target lowered to $26 from $52 at Piper Sandler
Premium
The Fly
Sage Therapeutics price target lowered to $26 from $52 at Piper Sandler
2M ago
Sage Therapeutics price target lowered to $14 from $25 at H.C. Wainwright
Premium
The Fly
Sage Therapeutics price target lowered to $14 from $25 at H.C. Wainwright
2M ago
Sage Therapeutics to reduce workforce by 33%, prioritize Zurzuvae
PremiumThe FlySage Therapeutics to reduce workforce by 33%, prioritize Zurzuvae
2M ago
Class Action Lawsuit Against Sage Therapeutics (NASDAQ:SAGE)
Premium
Market News
Class Action Lawsuit Against Sage Therapeutics (NASDAQ:SAGE)
2M ago
Nike upgraded, PayPal downgraded: Wall Street’s top analyst calls
Premium
The Fly
Nike upgraded, PayPal downgraded: Wall Street’s top analyst calls
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100